Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Oxurion NV TG40 | 79 | Stretched | Healthcare | Belgium | 3 / 6 | $32,622 |
| Work Medical Technology Group Ltd WOK | 52 | Elevated | Healthcare | China | 5 / 6 | $23,296 |
| STRATA Skin Sciences Inc SSKN | 64 | Stretched | Healthcare | United States | 5 / 6 | $1,178 |
| Aditxt Inc ADTX | 79 | Stretched | Healthcare | United States | 5 / 6 | $309 |
| Neovacs S.A. ALNEV | 56 | Elevated | Healthcare | France | 5 / 6 | $23 |
| Neovacs S.A. 0LW0 | 56 | Elevated | Healthcare | France | 5 / 6 | $11 |
| COSMO Pharmaceuticals SA 0RGI | 56 | Elevated | Healthcare | Ireland | 5 / 6 | -- |
| Ascom Holding AG 0QON | 46 | Elevated | Healthcare | Switzerland | 4 / 6 | -- |
| Selvaag Bolig ASA 0Q92 | 45 | Elevated | Healthcare | Norway | 3 / 6 | -- |
| Chugai Pharmaceutical Co. Ltd CUP | 41 | Elevated | Healthcare | Japan | 4 / 6 | -- |
| GIUNTI GPSY.MI | 35 | Normal | Healthcare | Italy | 5 / 6 | -- |
| Roche Holding AG RHO6 | 33 | Normal | Healthcare | Switzerland | 5 / 6 | -- |
| H Lundbeck A/S 0ND5 | 30 | Normal | Healthcare | Denmark | 3 / 6 | -- |
| Grifols SA GRF-P | 29 | Normal | Healthcare | Spain | 4 / 6 | -- |
By sector
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.